A single center, retrospective study of use of elexacaftor/tezacaftor/ivacaftor, Trikafta, in adult post-lung transplant recipients
Latest Information Update: 23 Sep 2021
Price :
$35 *
At a glance
- Drugs Elexacaftor/ivacaftor/tezacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 23 Sep 2021 New trial record
- 26 Aug 2021 Results published in the Journal of Heart and Lung Transplantation